Loading clinical trials...
Loading clinical trials...
Optic neuritis typically occurs in young (mean age, 32 years), female (77%) patients, and it presents as subacute monocular visual loss that develops over several days. As yet, treatment with intrave...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tehran University of Medical Sciences
NCT07100990 · Optic Neuritis, Myelitis, and more
NCT06453694 · Optic Neuritis
NCT03401879 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
NCT06776224 · Multiple Sclerosis, Optic Neuritis, Demyelinating Disease
NCT06389968 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
Eye Research Center Farabi Hosoital
Tehran
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions